Medeksa, MB - company info and details

Company age: 1 y. 8 mo.

Update

Company overview

Company name Medeksa, MB
Company code 307085757
VAT code LT100017583515
Registered address Vilnius, V. Nagevičiaus g. 3, LT-08237
Registration date 2025-02-04 Company age: 1 y. 8 mo.
Phone Phone
Email Email
Company manager For registered members only Log in
Revenue (2025) 132,484 € History
Profit (2025) 720 € History
Number of employees 3 History
Managed vehicles 2 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Processing and finishing of wood
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Medeksa, MB (company code 307085757) is an operational private small partnership registered in 2025. It belongs to the national private non-financial companies sector and is described as privately owned, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Governance is indicated as CEO only. The company is based in Vilnius, at V. Nageviciaus g. 3, in Vilniaus m. municipality, Vilniaus county.

Its core activity is classified under EVRK C.16.12.00, Processing and finishing of wood. In the latest financial year, 2025, the company generated revenue of EUR 132.5K over a 330-day period and reported net profit of EUR 720, with profit before tax of EUR 773. Profit margin was 0.5%. Total assets stood at EUR 29.8K, including EUR 2.1K in long-term assets and EUR 27.7K in short-term assets, while liabilities amounted to EUR 28.8K and equity to EUR 971. The financial structure therefore reflects a very small equity base relative to liabilities. Staff figures are not provided, and the latest staff year is recorded as so far in 2026.

Download a detailed company report

Make confident decisions with all the information about Medeksa, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report